Modeling the Long-Term Cost-Effectiveness of IDegLira in Patients with Type 2 Diabetes Who are Failing To Meet Glycemic Targets on Basal Insulin Alone in The Netherlands
Crossref DOI link: https://doi.org/10.1007/s13300-017-0266-3
Published Online: 2017-05-18
Published Print: 2017-08
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Hunt, Barnaby
Glah, Divina
van der Vliet, Maarten
Funding for this research was provided by:
Novo Nordisk
Text and Data Mining valid from 2017-05-18
Article History
Received: 5 April 2017
First Online: 18 May 2017